Maple Securities USA’s Allergan plc AGN Stock Holding History

Maple Securities USA’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-704	Closed	-$210K	–	337
2015 Q1	$210K	Buy	+704	New	+$201K	0.02%	220

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Maple Securities USA's AGN Position: Q2 2015 in Review

Maple Securities USA sold out of Allergan plc (AGN) in Q2 2015, closing a stake of 704 shares — an estimated $210K sold.

Maple Securities USA first reported a position in AGN in Q1 2015 and held it in 1 quarter. The position peaked at $210K in Q1 2015. 1,035 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

Maple Securities USA reported no remaining Allergan plc position as of Q2 2015 after selling out during the quarter.
Maple Securities USA sold 704 Allergan plc shares in Q2 2015, an estimated $210K.
Maple Securities USA first reported a position in Allergan plc in Q1 2015 and held it in 1 quarter.
Maple Securities USA's Allergan plc position peaked at $210K in Q1 2015.
1,035 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on Maple Securities USA's 13F filing for Q2 2015, filed 24 Jul 2015.